Purpose: To clarify the factors predictive of progression from ocular myasthenia gravis (OMG) to generalized MG (GMG) among patients with positive antiacetylcholine receptor antibodies (AChRAb) and to evaluate the efficacy of our OMG treatment protocol including tacrolimus (TAC).
Study Design: Retrospective study.
Methods: Fifty-two patients with AChRAb positivity and ptosis and/or eye movement disturbance showing diurnal fluctuation and fatigability were included.
Background/aims: To evaluate the effects of botulinum toxin type A (BTX-A) treatment in patients with benign essential blepharospasm (BEB) by monitoring the ocular surface and ocular higher-order aberrations (HOAs) before and after treatment.
Methods: The present study reports a prospective case series of 38 patients (76 eyes, 11 men and 27 women; mean age 66.8 ± 9.
Nippon Ganka Gakkai Zasshi
September 2007
Background: We report a case of fungal endophthalmitis which developed after subtenon injections of triamcinolone acetonide (TA).
Case: A 63-year-old man had Graves' ophthalmopathy. He had received subtenon injections of TA in his left eye.